{"id":"NCT01889862","sponsor":"BioMarin Pharmaceutical","briefTitle":"Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU","officialTitle":"A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07-29","primaryCompletion":"2016-01-13","completion":"2019-02-05","firstPosted":"2013-07-01","resultsPosted":"2019-07-12","lastUpdate":"2021-05-21"},"enrollment":215,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Phenylketonuria (PKU)"],"interventions":[{"type":"DRUG","name":"BMN165 20mg/day","otherNames":["PEG-PAL"]},{"type":"DRUG","name":"BMN165 40mg/day","otherNames":["PEG-PAL"]},{"type":"DRUG","name":"Placebo","otherNames":["Dextran 40"]}],"arms":[{"label":"BMN165 20mg/day","type":"ACTIVE_COMPARATOR"},{"label":"20 mg/day Placebo","type":"PLACEBO_COMPARATOR"},{"label":"BMN165 40mg/day","type":"ACTIVE_COMPARATOR"},{"label":"40 mg/day Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The BMN 165 clinical development program has been designed to demonstrate the safety and efficacy of BMN 165 in reducing blood Phe concentrations in adults with PKU.","primaryOutcome":{"measure":"Change From Baseline in the Blood Plasma Phenylalanine (Phe) Concentration at Part 2","timeFrame":"At Part 2 baseline and change from baseline at Part 2 week 8","effectByArm":[{"arm":"BMN165 20mg/Day","deltaMin":596.8,"sd":582.75},{"arm":"Placebo 20mg/Day","deltaMin":563.9,"sd":504.62},{"arm":"BMN165 40mg/Day","deltaMin":410.9,"sd":439.95},{"arm":"Placebo 40mg/Day","deltaMin":508.2,"sd":363.68}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG002 vs OG003","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":13,"exclusionCount":null},"locations":{"siteCount":29,"countries":["United States"]},"refs":{"pmids":["34826353"],"seeAlso":["http://www.pku.com"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":86},"commonTop":["Headache","Arthralgia","Nasopharyngitis","Upper respiratory tract infection","Injection site reaction"]}}